- Home
- RLX vs ITGR Comparison
RLX vs ITGR Comparison
Compare RLX & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLX
- ITGR
- Stock Information
- Founded
- RLX 2018
- ITGR 1970
- Country
- RLX China
- ITGR United States
- Employees
- RLX N/A
- ITGR N/A
- Industry
- RLX Medicinal Chemicals and Botanical Products
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RLX Health Care
- ITGR Health Care
- Exchange
- RLX Nasdaq
- ITGR Nasdaq
- Market Cap
- RLX 3.6B
- ITGR 4.1B
- IPO Year
- RLX 2021
- ITGR 2000
- Fundamental
- Price
- RLX $1.71
- ITGR $116.98
- Analyst Decision
- RLX Hold
- ITGR Strong Buy
- Analyst Count
- RLX 1
- ITGR 9
- Target Price
- RLX $2.50
- ITGR $146.00
- AVG Volume (30 Days)
- RLX 7.0M
- ITGR 752.3K
- Earning Date
- RLX 05-16-2025
- ITGR 04-24-2025
- Dividend Yield
- RLX 0.46%
- ITGR N/A
- EPS Growth
- RLX 7.27
- ITGR 25.44
- EPS
- RLX 0.06
- ITGR 3.37
- Revenue
- RLX $334,907,454.00
- ITGR $1,716,596,000.00
- Revenue This Year
- RLX $32.30
- ITGR $10.86
- Revenue Next Year
- RLX $17.63
- ITGR $7.41
- P/E Ratio
- RLX $29.16
- ITGR $34.41
- Revenue Growth
- RLX 96.50
- ITGR 10.35
- 52 Week Low
- RLX $1.50
- ITGR $104.93
- 52 Week High
- RLX $2.69
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- RLX 32.28
- ITGR 48.06
- Support Level
- RLX $1.66
- ITGR $114.37
- Resistance Level
- RLX $1.92
- ITGR $119.33
- Average True Range (ATR)
- RLX 0.09
- ITGR 5.67
- MACD
- RLX -0.00
- ITGR 0.72
- Stochastic Oscillator
- RLX 17.86
- ITGR 72.46
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.